12:00 AM
Jan 03, 2011
 |  BC Week In Review  |  Company News  |  Other News

Biotie autoimmune, pulmonary news

Biotie restructured and reduced headcount by 59 (73%) to 22 as part of its previously announced plans to discontinue its early-stage discovery efforts in order to focus on the...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >